Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,461	1,724	2,725	2,869	3,192	3,795
Market Cap Growth	110.34%	-36.74%	-5.01%	-10.13%	-15.90%	67.83%
Enterprise Value	3,572	2,011	2,906	2,602	3,246	3,552
Last Close Price	13.23	6.55	10.24	10.69	14.14	16.46
PE Ratio	-	-	-	129.62	50.04	10.97
Forward PE	-	61.78	61.78	61.78	61.78	61.78
PS Ratio	3.31	1.63	2.28	2.42	2.93	2.72
PB Ratio	2.69	1.34	1.96	1.91	3.22	3.68
P/TBV Ratio	3.21	1.58	2.33	2.40	4.72	5.49
P/FCF Ratio	-	-	-	-	-	9.80
P/OCF Ratio	50.42	-	21.12	20.39	39.60	8.33
EV/Sales Ratio	3.41	1.90	2.43	2.20	2.98	2.54
EV/EBITDA Ratio	-	-	33.12	69.06	29.86	7.97
EV/EBIT Ratio	-	-	77.76	-	44.71	8.30
EV/FCF Ratio	-40.36	-	-	-	-	9.17
Debt / Equity Ratio	0.55	0.50	0.42	0.28	0.36	0.26
Debt / EBITDA Ratio	144.40	647.00	6.13	9.59	3.15	0.60
Debt / FCF Ratio	-	-	-	-	-	0.69
Asset Turnover	0.42	0.42	0.48	0.57	0.66	1.09
Inventory Turnover	3.09	3.46	3.87	4.21	4.30	6.47
Quick Ratio	1.20	1.55	1.44	1.83	1.20	1.75
Current Ratio	1.62	1.97	1.78	2.21	1.67	2.20
Return on Equity (ROE)	-4.76%	-5.23%	-4.22%	1.97%	6.64%	43.53%
Return on Assets (ROA)	-1.69%	-1.64%	0.94%	-0.20%	2.73%	20.82%
Return on Invested Capital (ROIC)	-5.08%	-5.58%	3.25%	-0.61%	6.85%	51.56%
Return on Capital Employed (ROCE)	-3.90%	-3.60%	2.10%	-0.40%	5.90%	35.30%
Earnings Yield	-1.91%	-4.14%	-2.39%	0.77%	2.00%	9.12%
FCF Yield	-2.56%	-6.52%	-3.35%	-2.48%	-2.59%	10.21%
Dividend Yield	0.76%	-	-	1.25%	0.94%	1.62%
Payout Ratio	-	-	-	184.49%	91.47%	9.58%
Buyback Yield / Dilution	-1.95%	0.51%	-1.23%	-18.96%	0.26%	-0.26%
Total Shareholder Return	-1.21%	0.51%	-1.23%	-17.71%	1.20%	1.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.